MyndTec Inc.

MyndTec est une société canadienne de technologie médicale dédiée au développement et à la commercialisation de produits innovants qui améliorent la fonction, maximisent l'indépendance et améliorent la qualité de vie des personnes ayant subi une lésion du système nerveux central. à la suite d'un accident vasculaire cérébral, d'une lésion de la moelle épinière et de certaines lésions cérébrales traumatiques.

Français

MyndTec Inc.

MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries.  

Anglais

Caprock Mining Corp.

Caprock Mining Corp. is a Canadian gold exploration company focused on opportunities in the historical Beardmore-Geraldton Gold Belt (“BGB”) of Ontario. The company’s 100% interest in six gold exploration properties gives it a substantial landholding in the BGB - a belt that has produced over four million ounces of gold historically, and contains the world-class Greenstone gold project (formerly known as the Hardrock gold project) which is being brought to production by a joint venture partnership between Equinox Gold (TSE:EQX) and Orion Mine Finance.

Anglais

Pharmala Biotech Holdings Inc.

Pharmala se concentre sur la fabrication d'ingrédients pharmaceutiques actifs, de la classe des méthylènedioxyphénéthylamines substituées (« MDXX »), y compris la 3,4-méthylènedioxyméthamphétamine (« MDMA »). Pharmala a également l'intention d'entreprendre le développement de nouvelles formulations de MDMA et de la classe de composés MDXX, ainsi que le développement de nouvelles voies d'administration de médicaments pour ces molécules.

Français

Pharmala Biotech Holdings Inc.

Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class (“MDXX”), including 3,4-Methylenedioxymethamphetamine (“MDMA”). Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug delivery pathways for these molecules.

Anglais

Novamind Inc.

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.

Français

Novamind Inc.

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of integrative mental health clinics and operates a full-service contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.

Anglais